Application of teprenone in preparation of medicine for preventing and treating fatty liver/steatohepatitis

A technology for steatohepatitis and teprenone, applied in the field of compounds, can solve the problems of short duration of drug clinical trials, and achieve the effects of significant curative effect, reduced economic burden and high safety

Pending Publication Date: 2021-07-30
SIR RUN RUN HOSPITAL NANJING MEDICAL UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Despite the rapid development of drug research and development and clinical trials, due to the short duration of drug clinical trials, and the safety and effectiveness of long-term medication needs to be further clarified, there is still no approved drug for the treatment of fatty liver

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of teprenone in preparation of medicine for preventing and treating fatty liver/steatohepatitis
  • Application of teprenone in preparation of medicine for preventing and treating fatty liver/steatohepatitis
  • Application of teprenone in preparation of medicine for preventing and treating fatty liver/steatohepatitis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0025] The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

[0026] The application of teprenone in preparation prevention, treatment fatty liver / steatohepatitis medicine, test method comprises the following steps:

[0027] 1. Establishment and treatment of hepatic steatosis model in vitro

[0028] 1.1. Spread the FL83b mouse liver cell line on a 12-well plate;

[0029] 1.2. Configure high-fat medium (take 50ml as an example): add 200 μM sodium oleate solution and 100 μM Palmitic acid, mix upside down, add 1ml of high-fat ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses teprenone (the other name is pentatetraterpenone, and the chemical name is 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraterpene-2-one). The invention also relates to application of the compound in preparation of medicines for preventing and treating fatty liver/steatohepatitis. In addition to being prepared into capsules, the compound can also be prepared into tablets, powder, granules, oral liquid, injection and other medicine forms. In-vitro test results show that after FL83b cells of an in-vitro fatty degeneration model are stimulated by GGA for 24 hours, lipid droplets in the cells are obviously reduced; and animal experiment results are as follows: 12 weeks after continuous administration of 200mg/kg of GGA to a mouse with fatty liver induced by high fat-cholesterol-fructose diet, the weight gain of the mouse with high fat diet is reduced; meanwhile, the level of serum alanine aminotransferase is remarkably reduced, and the level of cholesterol is remarkably reduced; in addition, inflammation in liver tissues is remarkably relieved, and the fatty degeneration area is remarkably reduced; the serum insulin level is obviously reduced, and the insulin resistance is obviously improved. The medicine is remarkable in curative effect, high in safety, low in price and capable of relieving the economic burden of patients.

Description

technical field [0001] The invention relates to a new application of a compound, in particular to the application of teprenone in the preparation of drugs for the prevention and treatment of fatty liver / steatohepatitis. Background technique [0002] Fatty liver, (called non-alcoholic fatty liver in the past, and now also called metabolism-related fatty liver) is the most common health problem in the world at present, and its incidence rate is increasing year by year. It is estimated that the global prevalence rate reaches 25%. It has become the main cause of liver-related cardiovascular disease morbidity and death. Numerous studies have clearly shown that fatty liver is a metabolic disease and a hepatic manifestation of a systemic metabolic disorder. The 2020 international expert consensus suggests that non-alcoholic fatty liver disease be renamed metabolism-related fatty liver disease. In order to make the appellation consistent, it is uniformly referred to as "fatty live...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/121A61P1/16
CPCA61K31/121A61P1/16
Inventor 刘煜谢媛季旻珺
Owner SIR RUN RUN HOSPITAL NANJING MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products